Novel Anticoagulants Rapidly Adopted Into Clinical Practice

This article originally appeared here.
Share this content:
Novel Anticoagulants Rapidly Adopted Into Clinical Practice
Novel Anticoagulants Rapidly Adopted Into Clinical Practice

THURSDAY, Jan. 8, 2015 (HealthDay News) -- Novel anticoagulants have been rapidly adopted into clinical practice, and their use is associated with increased health care costs, according to a study published in the November issue of The American Journal of Medicine.

Using medical and prescription claims data from a large insurer, Nihar R. Desai, M.D., M.P.H., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues identified patients with nonvalvular atrial fibrillation who were prescribed an oral anticoagulant from 2010 to 2013. The authors examined trends in utilization over time and how the use of novel anticoagulants has impacted health spending for patients and insurers.

During the study period, the researchers identified 6,893 patients with atrial fibrillation who initiated an oral anticoagulant. Novel anticoagulants accounted for 62 percent of new prescriptions and 98 percent of anticoagulant-linked drug costs by the end of the study period. The odds of receiving a novel anticoagulant were significantly lower in association with female sex, lower household income, and higher CHADS2, CHA2DS2-VASC, and HAS-BLED scores (all P < 0.001). For patients initiating a novel anticoagulant, the average combined patient and insurer anticoagulant spending was more than $900 higher in the first six months after initiation.

"This study demonstrates rapid adoption of novel anticoagulants into clinical practice, particularly among patients with lower CHADS2 and HAS-BLED scores, and high health care cost consequences," the authors write.

The study was funded by an unrestricted grant from CVS Caremark; several authors are employed by CVS Caremark.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »